QuickView for aged 80 and over (biogroup)

1. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
2. L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
3. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
4. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
5. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)

PubMedClientImpl.search() failed to connect to SOLR server.

1. Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?
2. Mini-CHOP and Rituximab in Patients Aged Over 80 Years
3. Lenalidomide Combined With Rituximab as Front-line Therapy for DLBCL Patients Aged Over 80 Years
4. Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Y…
5. Study of Mini-Chop Plus Ofatumumab To Treat Cd 20+ Diffuse Large B-Cell Lymphoma In Patients Aged Ov…